Becton Dickinson & Co (BDX): Rasio rega marang prakiraan pendapatan

Logo perusahaan publik BD (BDX)

Stable demand for critical consumables from Becton Dickinson & Co (BDX) guarantees business resilience. Investments in molecular diagnostics and robotic pharmacies drive growth. The expected P/S valuation visualizes market expectations, where the 0.90 mark reflects the latest data. High regulatory barriers and patents make equipment replacement in clinics extremely difficult, cementing the company's dominance.

Becton Dickinson - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep BDX (periode 04.07.2022 - 13.11.2026)

Rincian analitis perusahaan Becton Dickinson & Company (BDX)

- rega saham lan target rega konsensus:
Kutipan saham Becton Dickinson|BDX - Prakiraan konsensus analis
- data kapitalisasi bursa:
Nilai pasar Becton Dickinson & Company|BDX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- indikator nilai buku ekuitas:
Nilai Buku saben Saham Becton Dickinson|BDX - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku bd.com|BDX - Total Aset Bisnis
- data tingkat utang lan likuiditas finansial:
Rasio Total Utang marang Ekuitas Becton Dickinson & Co|BDX - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang ekuitas Becton Dickinson & Co|BDX - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku Becton Dickinson & Company|BDX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Becton Dickinson|Rasio cepet bd.com
- rincian asil keuangan lan kelipatan valuasi:
BDX - Penghasilan resik|Bathi mangsa ngarep Becton Dickinson & Co|BDX - Rasio rega pasar marang bathi resik|Rega marang bathi mangsa ngarep Becton, Dickinson and Company|BDX - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Becton Dickinson & Company|BDX - Bathi operasional sadurunge amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Becton Dickinson|BDX - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan bd.com|BDX - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Becton Dickinson & Co
- rincian pendapatan lan dodolan:
BDX - Pendapatan reged perusahaan|Prakiraan volume dodolan Becton Dickinson|BDX - Kapitalisasi marang pendapatan|Rasio rega marang prakiraan pendapatan Becton Dickinson & Company
Analisis komprehensif perusahaan:Becton Dickinson BDX
Produk sing diprodhuksi Becton Dickinson & Co

To determine the fair value of Becton Dickinson & Co (BDX), utilize the market capitalization to projected revenue ratio, which measures the market's willingness to pay a premium per unit of future sales. By analyzing the projected P/S value, an investor assesses consensus expectations regarding business efficiency and valuation risks. The stability of this multiple confirms the company's dominance in the consumables market, where production scale allows Becton Dickinson & Co (BDX) to maintain premium pricing power.

Karo sapa Becton Dickinson & Co saingan

Intuitive - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Danaher Corporation DHR|STE - Rasio rega marang prakiraan pendapatan|West Pharma Corp (WST) - Multiplikator forward rega marang pendapatan|BAX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep masimo.com (MASI)|Rasio rega marang prakiraan pendapatan Stevanato Group|Kapitalisasi marang prakiraan pendapatan TFX (Teleflex Inc.)|Multiplikator forward rega marang pendapatan MMSI (Merit Medical Systems Inc)|Rasio rega marang pendapatan sing dikarepake NVST|Rasio rega marang prakiraan pendapatan ICU Medical, Inc. ICUI|Rasio kapitalisasi marang dodolan sing dikarepake dentsplysirona.com (XRAY)|LeMaitre Vascular - Multiplikator Forward P/S|ATRC: Rasio rega marang prakiraan pendapatan|STAA: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Niagen (NAGE)|ZIMV (ZimVie Inc.) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan angiodynamics.com (ANGO)|Multiplikator forward rega marang pendapatan CERS (Cerus)|Rasio rega marang pendapatan sing dikarepake TKNO|Rasio rega marang prakiraan pendapatan Monogram Technologies Inc MGRM|Sharps Technology Inc (STSS) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|INFU - Rasio rega marang prakiraan pendapatan|UTMD (utahmed.com) - Kapitalisasi marang prakiraan pendapatan|KRMD (korumedical.com) - Multiplikator forward rega marang pendapatan|Nyxoah SA - Rega forward marang dodolan|MBOT (Microbot Medical Inc) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PDEX (Pro-Dex Inc.)|Multiplikator Forward P/S ZTEK|Rasio kapitalisasi marang dodolan sing dikarepake elutia.com|Multiplikator Forward P/S MLSS (Milestone Scientific Inc.)|NXGL - Multiplikator forward rega marang pendapatan|RVP - Rasio rega marang prakiraan pendapatan|HBIO - Multiplikator Forward P/S|FEMY: Multiplikator Forward P/S|MHUA - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Predictive Oncology Inc|Kapitalisasi marang prakiraan pendapatan CJMB (Callan JMB Corp)|Rasio rega marang prakiraan pendapatan Atrion Corp (ATRI)|Rasio kapitalisasi marang dodolan sing dikarepake NeuroMetrix Corporation